Hospice Pain Control: Developing an Opioid Order Sheet
临终关怀疼痛控制:制定阿片类药物订单表
基本信息
- 批准号:6953440
- 负责人:
- 金额:$ 16.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-13 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Despite the availability of effective pharmaceutical agents, pain is a common and often devastating symptom control problem at end-of-life. We have formulated a model that describes "criteria for adequate pain control" in the outpatient oncology setting. Based on this theoretical model, we have developed a protocol which is testing an opioid titration order sheet structured to provide clear direction for three critical provider behaviors: (1) pain assessment, (2) generation of a treatment plan, and (3) communication of the treatment plan to the patient. The use of a similar order sheet may enhance pain control in the hospice setting; however, the needs and potential barriers to adequate pain control within the hospice setting are unique and largely uninvestigated. Furthermore, the burden imposed by the current clinical protocol on patients and caregivers is excessive for the hospice setting and the primary endpoints are not appropriate to the terminal patient population. Hospice specific factors which may affect pain outcome and/or require alterations in the clinical protocol include: (1) the increasing role of caregivers, (2) the shift to home based care, (3) introduction of hospice staff as part of the health care team, (4) the decreasing role of the primary care team and (5) medical complications of the disease process. Thus, modification of the theoretical model, the opioid titration order sheet, and the protocol, will be necessary in order to test this intervention in the hospice population. Using a mixed methods approach, we propose to identify the unique needs and barriers for pain control in the hospice setting as identified by key stakeholders (patients, caregivers, hospice staff and referring physicians). Based on these data we will modify the theoretical model, the order sheet and the protocol. Once the modifications lave been made, we will conduct a pilot study to assess feasibility, utility and efficacy of the order sheet in the outpatient hospice setting.
描述(由申请人提供):尽管有有效的药物制剂,但疼痛是一种常见的,往往是毁灭性的症状控制问题,在生命的尽头。我们已经制定了一个模型,描述了“充分控制疼痛的标准”在门诊肿瘤设置。基于这一理论模型,我们开发了一种方案,该方案正在测试阿片类药物滴定订单,该订单旨在为三个关键的提供者行为提供明确的指导:(1)疼痛评估,(2)生成治疗计划,以及(3)将治疗计划传达给患者。使用类似的医嘱单可能会提高临终关怀环境中的疼痛控制;然而,临终关怀环境中充分控制疼痛的需求和潜在障碍是独特的,并且在很大程度上未经调查。此外,当前临床方案对患者和护理人员造成的负担对于临终关怀环境来说是过度的,并且主要终点不适合终末患者人群。可能影响疼痛结局和/或需要改变临床方案的临终关怀特定因素包括:(1)护理人员的作用日益增加,(2)转向家庭护理,(3)引入临终关怀人员作为医疗保健团队的一部分,(4)初级保健团队的作用日益减少,(5)疾病过程的医疗并发症。因此,修改的理论模型,阿片类药物滴定订单,和协议,将是必要的,以测试这种干预在临终关怀人口。使用混合方法的方法,我们建议确定的独特需求和障碍,疼痛控制在临终关怀设置确定的关键利益相关者(患者,护理人员,临终关怀工作人员和转诊医生)。基于这些数据,我们将修改理论模型,订单和协议。一旦修改完成,我们将进行一项试点研究,以评估在门诊临终关怀设置的可行性,实用性和有效性的订单。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara A. Murphy其他文献
Development of a model for inducing transient insulin resistance in the mare: preliminary implications regarding the estrous cycle.
开发用于诱导母马短暂胰岛素抵抗的模型:对发情周期的初步影响。
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:3.3
- 作者:
D. R. Sessions;Stephanie E. Reedy;M. M. Vick;Barbara A. Murphy;B. Fitzgerald - 通讯作者:
B. Fitzgerald
Longitudinal oncology registry of head and neck carcinoma (LORHAN®): initial supportive care findings
头颈癌纵向肿瘤学登记 (LORHAN®):初步支持治疗结果
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:3.1
- 作者:
Barbara A. Murphy;Amy Y. Chen;Walter J. Curran;A. Garden;P. Harari;Stuart J. Wong;K. Ang - 通讯作者:
K. Ang
Oral health in oncology: impact of immunotherapy
- DOI:
10.1007/s00520-014-2434-6 - 发表时间:
2014-09-13 - 期刊:
- 影响因子:3.000
- 作者:
Leanne K. Jackson;Douglas B. Johnson;Jeffrey A. Sosman;Barbara A. Murphy;Joel B. Epstein - 通讯作者:
Joel B. Epstein
Interferon regulatory factor‐1 is a major regulator of epidermal growth factor receptor gene expression
干扰素调节因子-1是表皮生长因子受体基因表达的主要调节因子
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:3.5
- 作者:
Y. Rubinstein;Kimberle N Proctor;M. Bergel;Barbara A. Murphy;A. Johnson - 通讯作者:
A. Johnson
Mobile blue light therapy is as effective as stable lighting at advancing seasonal reproductive activity in mares
- DOI:
10.1016/j.jevs.2013.10.070 - 发表时间:
2014-01-01 - 期刊:
- 影响因子:
- 作者:
Caroline M. Walsh;Elizabeth M. Woodward;Ralph L. Prendergast;James P. Rylei;Luke H. Fallon;Mats H.T. Troedsson;Barbara A. Murphy - 通讯作者:
Barbara A. Murphy
Barbara A. Murphy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara A. Murphy', 18)}}的其他基金
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
头颈癌的纤维化-淋巴水肿连续体
- 批准号:
8098131 - 财政年份:2010
- 资助金额:
$ 16.04万 - 项目类别:
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
头颈癌的纤维化-淋巴水肿连续体
- 批准号:
8541621 - 财政年份:2010
- 资助金额:
$ 16.04万 - 项目类别:
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
头颈癌的纤维化-淋巴水肿连续体
- 批准号:
8255582 - 财政年份:2010
- 资助金额:
$ 16.04万 - 项目类别:
Hospice Pain Control: Developing an Opioid Order Sheet
临终关怀疼痛控制:制定阿片类药物订单表
- 批准号:
7121936 - 财政年份:2005
- 资助金额:
$ 16.04万 - 项目类别:
PHASE I/II AND PHARMACOLOGIC STUDYOF PACLITAXEL GIVEN AS 96 HOUR INFUSION
紫杉醇 96 小时输注的 I/II 期和药理学研究
- 批准号:
6246776 - 财政年份:1997
- 资助金额:
$ 16.04万 - 项目类别:
DOSE RANGING EFFICACY, SAFETY, AND PHARMACOKINETIC STUDY OF RS25259
RS25259 的剂量范围疗效、安全性和药代动力学研究
- 批准号:
5219416 - 财政年份:
- 资助金额:
$ 16.04万 - 项目类别:
相似海外基金
Peripherally-restricted non-addictive cannabinoids for cancer pain treatment
用于癌症疼痛治疗的外周限制性非成瘾大麻素
- 批准号:
10726405 - 财政年份:2023
- 资助金额:
$ 16.04万 - 项目类别:
Novel molecular mechanism of oral cancer pain focused attention on plastic changes in intercellular network in the trigeminal ganglion
口腔癌疼痛的新分子机制关注三叉神经节细胞间网络的可塑性变化
- 批准号:
23H03108 - 财政年份:2023
- 资助金额:
$ 16.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Intra-tumoral neurons contribute to head and neck cancer pain
肿瘤内神经元导致头颈癌疼痛
- 批准号:
10635591 - 财政年份:2023
- 资助金额:
$ 16.04万 - 项目类别:
Development and piloting of an intervention to reduce the impact of opioid stigma in cancer pain
开发和试点一项干预措施,以减少阿片类药物耻辱对癌症疼痛的影响
- 批准号:
10448644 - 财政年份:2022
- 资助金额:
$ 16.04万 - 项目类别:
Identifying non-opioid strategies to manage oral cancer pain
确定非阿片类药物策略来控制口腔癌疼痛
- 批准号:
10617001 - 财政年份:2022
- 资助金额:
$ 16.04万 - 项目类别:
Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors
癌症疼痛管理:针对亚裔美国乳腺癌幸存者的基于技术的干预措施
- 批准号:
10931208 - 财政年份:2022
- 资助金额:
$ 16.04万 - 项目类别:
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial
通过社会文化知情、数字化的癌症疼痛管理 NT™ (ASCENT) 临床试验实现公平
- 批准号:
10539159 - 财政年份:2022
- 资助金额:
$ 16.04万 - 项目类别:
Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance
靶向 HB-EGF 和三叉神经 EGFR 治疗口腔癌疼痛和阿片类药物耐受
- 批准号:
10582847 - 财政年份:2022
- 资助金额:
$ 16.04万 - 项目类别:
Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors
癌症疼痛管理:针对亚裔美国乳腺癌幸存者的基于技术的干预措施
- 批准号:
10595357 - 财政年份:2022
- 资助金额:
$ 16.04万 - 项目类别: